Literature DB >> 3528114

A new photometric method for oxygen consumption measurements in cell suspensions.

W Mueller-Klieser, R Zander, P Vaupel.   

Abstract

A new technique is described for measuring O2 consumption rates and O2 concentrations in suspensions of respiring cells. Aliquots of a cell suspension kept in a special thermostated precision syringe are injected into the measuring system in defined time intervals. The O2 content of these samples is determined photometrically, as reported previously. The O2 consumption per cellular wet weight and/or per single cell can be calculated from the cell volume fraction, the physical density, the cell concentration in the suspension, and the time-dependent decline of the O2 concentration in the precision syringe. The minimum detectable amount of O2 is 0.1 microliter O2, which corresponds to 0.001 (vol/vol) of O2 if a 100-microliters sample of suspended cells is analyzed. Reproducibility of the O2 consumption measurement is 9% of the measured value. The advantages offered by this method are the straightforward calibration in absolute terms, the short time required for one analysis (2-6 min), a high sensitivity, the simultaneous determination of overall O2 concentration and O2 consumption rates in cell suspensions, and the great variability in the application.

Entities:  

Mesh:

Year:  1986        PMID: 3528114     DOI: 10.1152/jappl.1986.61.2.449

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  3 in total

1.  Oxygen-controlled three-dimensional cultures to analyze tumor angiogenesis.

Authors:  Scott S Verbridge; Nak Won Choi; Ying Zheng; Daniel J Brooks; Abraham D Stroock; Claudia Fischbach
Journal:  Tissue Eng Part A       Date:  2010-07       Impact factor: 3.845

2.  Staphylococcal alpha-toxin kills human keratinocytes by permeabilizing the plasma membrane for monovalent ions.

Authors:  I Walev; E Martin; D Jonas; M Mohamadzadeh; W Müller-Klieser; L Kunz; S Bhakdi
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

3.  In vivo targets of recombinant human tumour necrosis factor-alpha: blood flow, oxygen consumption and growth of isotransplanted rat tumours.

Authors:  F Kallinowski; C Schaefer; G Tyler; P Vaupel
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.